TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: facial skin blood flow reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Parental satisfaction rates
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Unscheduled return visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Efficacy and safety of daprodustat compared with darbepoetin alfa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hemoglobin A1c reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Seizure frequency score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Histopathologic changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Postoperative additional analgesic needs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Serum alpha-fetoprotein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of overall treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: 15-year cumulative survival rate
Endpoint domain: Mortality/survival
Primary endpoint: major adverse events-free survival rate
Endpoint domain: Adverse events/effects
Primary endpoint: repeat revascularisation-free rate
Endpoint domain: Adverse events/effects
Primary endpoint: asthma control scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: elevated cortisol levels at wake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: elevated cortisol levels 45-min postwake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: cortisol levels 12 hr postwake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Positive SARS-CoV-2 RT-PCR tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Systemic 11β‐hydroxysteroid dehydrogenase (11β‐HSD1) activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 5α‐reductase activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Headache-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Distant metastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morcellation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: acute post-procedural pain level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pre-procedural anxiety level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bowel cleansing success rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High-quality bowel cleansing success rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PDR (Proportion of patients with successful bowel cleansing)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AI vs human FNA comparison
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement on standard area definition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variation in visual PGT estimates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first postoperative remedial analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative NRS score
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Intraoperative and postoperative sufentanil consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Changes in EQ-5D score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in HAMD, SDS and Kupperman scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hand-grip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: ability of self-management
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: ability to cooperate
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: 5-year DMFS
Endpoint domain: Mortality/survival
Primary endpoint: 5-year LFRS
Endpoint domain: Mortality/survival
Primary endpoint: Probability of adhering to step- and minute-based goals
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Diagnostic value of biomarkers for periodontitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ABK performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: points per game
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Reduction in plasma N-palmitoylsphingosine (Cer 16:0)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in plasma N-tetracosanoylsphingosine (Cer 24:0)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Enhancement of cholesterol efflux capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of pruritus (requiring treatment)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ESQ scores post-cooling
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: pathologic complete response (pCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: tumor uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parallel Walk Test performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 10mTW Test performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in CD3+%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Increase in CD4+%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Efficacy of intravitreal corticosteroid implants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subluxation distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: modified Barthel index
Endpoint domain: Life impact
Endpoint subdomain: Independence in daily living
Primary endpoint: visual memory performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: hemodynamic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recommendation to a friend
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Five-year major adverse cardiac event rates
Endpoint domain: Mortality/survival
Primary endpoint: Adjusted mean AUCτ,30‐32
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adjusted mean Cmax,30‐32
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication engagement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parent participation
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Duration of stay in PACU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dysphagia symptoms at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Swallowing-Quality of Life (SWAL-QOL) scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean phenylephrine equivalent needed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of tachycardia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pelvic floor morphometry during coughs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PFM function during contractions and coughs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-efficacy in performing PFM exercises
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Migraine attack duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of S. mutans
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mean frequency of rebound hypoglycemia events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean duration of rebound hypoglycemia events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean severity of rebound hypoglycemia events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: salivary biomarkers of bone remodelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RMAA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mayo Elbow Performance scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bony union
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported confidence with skills
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Bruise size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bruise color
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing course duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FRAIL scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reversion from pre-frail/frail to robust status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: comprehensive assessments of older adults
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: enhancing patient‐focused care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: improving teamwork and collaboration
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Improvement in frailty status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of Yale‐Brown Obsessive Compulsive Scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FMA (motor function) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of retinal re-detachment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anterior chamber fibrin exudation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posterior iris synechia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BEHKA‐HIV
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 25(OH)D concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 5 m sprint test performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative STAI-1 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in STAI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: craniocervical flexion test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chlamydia prevalence
Endpoint domain: Adverse events/effects
Primary endpoint: Gonorrhoea prevalence
Endpoint domain: Adverse events/effects
Primary endpoint: Crestal ridge width
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of vital mineralized tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: PROMIS Pain Interference Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in mindfulness skills
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: reduction in tendency to brooding
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: increase in positive vision of the future
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Quality-adjusted life-years (QALY) gained
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: quality of life related to breast cancer
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Behavioural intention scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Tinnitus severity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tinnitus volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total therapeutic effectiveness rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sperm DFI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in total phenolics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in mineral micronutrients (Co, I, Mn)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increase in plasma Se concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: probing depth change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase of activated CD3+CD4+CD25+
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Increase of CD4+CD25+CD127Low (Treg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: endoscopic remission rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perception of health risks to smoking e-cigs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge of e-cigs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Formal education regarding e-cigs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: mean decrease in urge urinary incontinence episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in child cotinine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceived general health status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 15N:13C enrichment ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: general executive function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: community walking ability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Postprandial triglycerides (TG) concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: RLP cholesterol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of patients reaching target HbA1c <7%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sedation as an adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Effectiveness of communication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DF ROM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Passive torque at DF ROM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADHD‐RS‐IV total score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CGI‐I scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PGI‐I scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: percent improvement in depression symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: response rate in depression symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: remission rate in depression symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in oral diadochokinesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-reported communication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Satisfaction with the teaching method
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pain perception during NCS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urine retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posttraumatic Stress Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CTX-I changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: COMP changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Total nicotine exposure (AUC0-t-BL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intravascular injection rate
Endpoint domain: Adverse events/effects
Primary endpoint: Epidural spread rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade III–IV treatment-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Scores above cut-off for all three instruments (MADRS-S, GAD-7, KEDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: trait anger
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anger control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VTS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of clinical outcomes as the primary efficacy end point
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual analog scale pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morphine equivalent consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KSS Knee and Function scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in LM scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Migraine incidence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of severe migraines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in stability indexes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total QoR-40 scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of intraoperative bradycardia
Endpoint domain: Adverse events/effects
Primary endpoint: Local Recurrence-Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: FEF25–75 increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: AUC for discriminating lung metastases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-h ambulatory blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Chemotherapy tolerability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment gap between cycles
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Effective rate of the research group
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Functional mobility improvement (TUG test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life improvement (WHOQOL-OLD score)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Dystrophin production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Timed function tests improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression to Cervical Intraepithelial Neoplasia grade 2 or worse (CIN2+)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Muscular activation of the peroneus longus muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inflammatory cell aggregation in lung tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Levels of IL-6, IL-23, and IFN-β in lung tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: language at 18 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: standing and walking at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes